Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Zanganeh Maky
Relationship:   Chief Executive Office...
City:   Sunnyvale
State:   CA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   1,125,725    

Indirect Shares

   198,074      
Direct Value   $7,036,769    

Indirect Value

   $1,378,458      
Total Shares   1,323,799      
Total Value   $8,415,227      


Pulse Biosciences, Inc. $4,724,355 Summit Therapeutics Inc $2,312,414 Pulse Biosciences, Inc. $4,724,355 Summit Therapeutics Inc $2,312,414
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    11   
    0    

     Stock price went up :
    10   
    0    
     Stock price went down :
    1   
    0    
   
     Gain/Loss Ratio :
   10.0   
   0.0   
     Percentage Gain/Loss :
   62.6%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Pharmacyclics Inc PCYC Chief Operating Officer 2015-05-26 0 2015-05-26 0    Premium*  
            Pulse Biosciences, Inc. PLSE Director 2023-11-13 604,911 2023-11-13 148,074    Premium*  
            Summit Therapeutics Inc SMMT Chief Executive Office... 2024-03-27 520,814 2024-03-27 50,000    Premium*  
* Premium Members only  

Records found :    66         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
PCYC Pharmacyclics Inc Chief Operating Officer   •       –      –    2015-03-12 4 OE $0.75 $69,375 D/D 92,500 317,812 0 -
SMMT Summit Therapeutics Inc Chief Executive Officer   •       •      –    2024-03-27 4 B $3.72 $96,720 D/D 26,000 520,814 2.81 %
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-03-20 4 B $22.71 $98,305 I/I 4,280 46,714 2.1 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-05-10 4 B $21.71 $108,545 I/I 5,000 85,474 2.1 -
PCYC Pharmacyclics Inc Chief Operating Officer   •       –      –    2015-03-12 4 OE $2.30 $110,904 D/D 48,219 366,031 0 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-03-20 4 B $22.47 $112,360 D/D 5,000 263,935 2.39 -
SMMT Summit Therapeutics Inc Chief Executive Officer   •       •      –    2024-03-26 4 B $3.75 $112,500 I/I 30,000 30,000 2.66 %
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-08-03 4 B $23.00 $115,015 I/I 5,000 90,474 2.1 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-09-18 4 B $15.02 $116,791 D/D 7,775 332,500 2.39 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2020-06-15 4 OE $7.01 $140,200 D/D 20,000 352,500 0 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-02-15 4 B $11.97 $155,649 I/I 13,000 33,474 2.1 -
PLSE Pulse Biosciences, Inc. Director   •       •      –    2023-11-13 4 OE $2.14 $162,801 D/D 76,075 604,911 0 -
PLSE Pulse Biosciences, Inc. Director   •       •      –    2023-06-09 4 OE $2.05 $177,669 D/D 86,668 791,915 0 -
PLSE Pulse Biosciences, Inc. Director   •       •      –    2023-06-09 4/A OE $2.05 $177,669 D/D 86,668 528,836 0 -
SMMT Summit Therapeutics Inc Co-CEO & President   •       •      –    2022-08-16 4 B $0.97 $178,897 D/D 184,430 359,969 2.81 %
PCYC Pharmacyclics Inc Chief Operating Officer   •       –      –    2015-03-12 4/A OE $0.75 $180,279 D/D 140,719 366,031 0 -
SMMT Summit Therapeutics Inc Chief Executive Officer   •       •      –    2024-03-27 4 B $3.71 $201,874 I/I 54,321 50,000 2.66 %
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-08-02 4 B $25.15 $208,469 D/D 8,290 287,225 2.39 -
PCYC Pharmacyclics Inc Chief Operating Officer   •       –      –    2014-11-07 4 S $135.01 $209,401 D/D (1,551) 210,312 0 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-03-17 4 B $24.00 $215,004 I/I 8,960 42,434 2.1 -
PCYC Pharmacyclics Inc Chief Operating Officer   •       –      –    2015-03-11 4 OE $7.19 $215,700 D/D 30,000 255,312 0 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-09-14 4 B $12.23 $280,879 D/D 22,000 324,725 2.39 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-05-11 4 B $20.84 $312,540 D/D 15,000 278,935 2.39 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-08-03 4 B $23.23 $366,317 D/D 15,500 302,725 2.39 -
SMMT Summit Therapeutics Inc Chief Executive Officer   •       •      –    2023-12-11 4 OE $1.58 $498,776 I/I 315,681 24,889,479 0 -
  66  Records found
  1   2  3      
  Page 2 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us